0001192482-17-000021.txt : 20170127 0001192482-17-000021.hdr.sgml : 20170127 20170127094637 ACCESSION NUMBER: 0001192482-17-000021 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170127 DATE AS OF CHANGE: 20170127 EFFECTIVENESS DATE: 20170127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Interpace Diagnostics Group, Inc. CENTRAL INDEX KEY: 0001054102 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 222919486 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-279433 FILM NUMBER: 17551879 BUSINESS ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING A, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (855) 776-6419 MAIL ADDRESS: STREET 1: MORRIS CORPORATE CENTER 1, STREET 2: BUILDING A, 300 INTERPACE PARKWAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: PDI INC DATE OF NAME CHANGE: 20021113 FORMER COMPANY: FORMER CONFORMED NAME: PROFESSIONAL DETAILING INC DATE OF NAME CHANGE: 19980129 D 1 primary_doc.xml X0707 D LIVE 0001054102 Interpace Diagnostics Group, Inc. MORRIS CORPORATE CENTER 1, BUILDING A, 300 INTERPACE PARKWAY PARSIPPANY NJ NEW JERSEY 07054 (855) 776-6419 DELAWARE PDI INC PROFESSIONAL DETAILING INC Corporation true Jack E Stover Morris Corporate Center 1 Building A, 300 Interpace Parkway Parsippany NJ NEW JERSEY 07054 Executive Officer Director President and CEO James Early Morris Corporate Center 1 Building A, 300 Interpace Parkway Parsippany NJ NEW JERSEY 07054 Executive Officer CFO Stephen J Sullivan Morris Corporate Center 1 Building A, 300 Interpace Parkway Parsippany NJ NEW JERSEY 07054 Director Joseph Keegan Morris Corporate Center 1 Building A, 300 Interpace Parkway Parsippany NJ NEW JERSEY 07054 Director Other Health Care $5,000,001 - $25,000,000 06b false 2017-01-20 false true true false 0 Maxim Group LLC 120708 None None 405 Lexington Avenue New York NY NEW YORK 10174 NJ NEW JERSEY NY NEW YORK false 4121100 111150 4009950 Reflects (i) proceeds from sale of warrants with a 5 year exercise period to purchase an aggregate of 855,000 shares of common stock, at an allocated price of $0.13 per warrant and an exercise price of $4.69 and (ii) proceeds if all warrants are exercised false 6 329688 true 0 Reflects (i) amount paid in connection with the sale of warrants in this offering and (ii) amount payable if all warrants are exercised. 111000 true Pursuant to his Employment Agreement with the Issuer, Mr. Stover is entitled to receive a bonus equal to 3% of the net proceeds received by the Issuer from the sale of warrants in this offering and a concurrent public offering. false Interpace Diagnostics Group, Inc. /s/ Jack E. Stover Jack E. Stover President and Chief Executive Officer 2017-01-26